{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:39:00Z","timestamp":1790789940248,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM121595"],"award-info":[{"award-number":["R01GM121595"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA233945"],"award-info":[{"award-number":["1R01CA233945"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"U.S. Department of Health & Human Services | NIH | Center for Scientific Review","doi-asserted-by":"publisher","award":["1R01CA233945"],"award-info":[{"award-number":["1R01CA233945"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41379-022-01063-1","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T06:04:30Z","timestamp":1648015470000},"page":"1220-1226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage"],"prefix":"10.1016","volume":"35","author":[{"given":"Kerri-Ann","family":"Latchmansingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro E.","family":"Verdun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-2096","authenticated-orcid":false,"given":"Mario L.","family":"Marques-Piubelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-452X","authenticated-orcid":false,"given":"Francisco","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. James","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-9013","authenticated-orcid":false,"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01063-1_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","article-title":"How I treat T-cell acute lymphoblastic leukemia in adults","volume":"126","author":"Litzow","year":"2015","journal-title":"Blood"},{"key":"10.1038\/s41379-022-01063-1_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-022-01063-1_bib3","unstructured":"Borowitz M. J., et al., editor. WHO classification of tumours of haematopoietic and lymphoid tissues. 4 ed. 209\u2013212 (IARC: Lyon, 2017)."},{"key":"10.1038\/s41379-022-01063-1_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ajh.26144","article-title":"Outcome of T-cell acute lymphoblastic leukemia\/lymphoma: focus on near-ETP phenotype and differential impact of nelarabine","volume":"96","author":"Morita","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1038\/s41379-022-01063-1_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1038\/s41379-022-01063-1_bib6","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"key":"10.1038\/s41379-022-01063-1_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/s41379-022-01063-1_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.15252\/embj.201490542","article-title":"Scl binds to primed enhancers in mesoderm to regulate hematopoietic and cardiac fate divergence","volume":"34","author":"Org","year":"2015","journal-title":"EMBO J"},{"key":"10.1038\/s41379-022-01063-1_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ni.1978","article-title":"Nuclear adaptor Ldb1 regulates a transcriptional program essential for the maintenance of hematopoietic stem cells","volume":"12","author":"Li","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1038\/s41379-022-01063-1_bib10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20042524","article-title":"New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling","volume":"201","author":"Dik","year":"2005","journal-title":"J Exp Med"},{"key":"10.1038\/s41379-022-01063-1_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/77819","article-title":"SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression","volume":"1","author":"Herblot","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1038\/s41379-022-01063-1_bib12","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2006-04-019927","article-title":"The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia","volume":"108","author":"Van Vlierberghe","year":"2006","journal-title":"Blood"},{"key":"10.1038\/s41379-022-01063-1_bib13","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood-2016-09-742148","article-title":"Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia","volume":"129","author":"Rahman","year":"2017","journal-title":"Blood"},{"key":"10.1038\/s41379-022-01063-1_bib14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.2019000095","article-title":"LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis","volume":"134","author":"Morishima","year":"2019","journal-title":"Blood"},{"key":"10.1038\/s41379-022-01063-1_bib15","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3324\/haematol.2018.207837","article-title":"ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms","volume":"104","author":"Goossens","year":"2019","journal-title":"Haematologica"},{"key":"10.1038\/s41379-022-01063-1_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ccell.2019.07.007","article-title":"LMO2 confers synthetic lethality to PARP inhibition in DLBCL","volume":"36","author":"Parvin","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1038\/s41379-022-01063-1_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jmoldx.2018.08.002","article-title":"Ultra-rapid reporting of GENomic targets (URGENTseq): clinical next-generation sequencing results within 48 h of sample collection","volume":"21","author":"Patel","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1038\/s41379-022-01063-1_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-022-01063-1_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1038\/s41379-022-01063-1_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"10.1038\/s41379-022-01063-1_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-022-01063-1_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-022-01063-1_bib23","doi-asserted-by":"crossref","first-page":"150062","DOI":"10.1098\/rsob.150062","article-title":"LMO2 at 25 years: a paradigm of chromosomal translocation proteins","volume":"5","author":"Chambers","year":"2015","journal-title":"Open Biol"},{"key":"10.1038\/s41379-022-01063-1_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymthe.2005.09.010","article-title":"The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion","volume":"13","author":"Nam","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/s41379-022-01063-1_bib25","first-page":"587","article-title":"Expression of the proto-oncogene rhombotin-2 is identical to the acute phase response protein metallothionein, suggesting multiple functions","volume":"6","author":"Neale","year":"1995","journal-title":"Cell Growth Differ"},{"key":"10.1038\/s41379-022-01063-1_bib26","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2010-07-293357","article-title":"Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex","volume":"117","author":"El Omari","year":"2011","journal-title":"Blood"},{"key":"10.1038\/s41379-022-01063-1_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ajcp\/aqv024","article-title":"LMO2 is a specific marker of T-lymphoblastic leukemia\/lymphoma","volume":"145","author":"Jevremovic","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-022-01063-1_bib28","doi-asserted-by":"crossref","first-page":"e0193098","DOI":"10.1371\/journal.pone.0193098","article-title":"Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach","volume":"13","author":"de Jong","year":"2018","journal-title":"PLoS One"},{"key":"10.1038\/s41379-022-01063-1_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/10428194.2021.1984453","article-title":"Olaparib combined with chemotherapy for treatment of T-cell acute lymphoblastic leukemia relapse after unrelated umbilical cord blood transplantation","volume":"63","author":"Xue","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/s41379-022-01063-1_bib30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2011.040568","article-title":"LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome","volume":"96","author":"Malumbres","year":"2011","journal-title":"Haematologica"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01063-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01063-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222002770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01063-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:30:40Z","timestamp":1760229040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222002770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0893395222002770"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01063-1","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01063-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}